The U.S. Consumer Product Safety Commission (CPSC) has warned consumers about using Doraemon Dovfun Suit Magnetic Ball Sets. It has come to light that these products contain loose magnets that pose a significant risk to individuals, especially children.
Reuters reported that seven deaths have already occurred as a result of ingestion.
Non-Compliance With Safety Regulations
According to PR Newswire, CPSC testing has revealed that the magnetic ball sets do not meet the requirements set forth by federal toy regulations. One or more magnets in the sets exceed the permissible strength, and these magnets are of a size that can easily fit within the small parts cylinder as defined by CPSC guidelines.
Potential Dangers and Consequences
After ingestion, the ingested magnets can attract to each other or other metal objects within the digestive system. This can lead to various complications, such as perforations, twisting, blockage of the intestines, infection, blood poisoning, and, in severe cases, death. It is estimated that from 2017 to 2021, approximately 2,400 magnet ingestions were treated in hospital emergency departments in the United States alone.
Inaction From the Seller
Despite a Notice of Violation issued to Doraemon, the Chinese seller of these magnetic ball sets, no action has been taken to address the issue. There is no recall of the product or offer of a remedy to consumers. This lack of response from Doraemon is concerning and raises further alarm about the safety of their products.
The magnetic ball sets were sold online at Amazon.com and were priced at around $25. Each set consisted of multi-colored magnetic balls arranged in a cube shape. These sets were sold encased in a clear plastic case and packaged in a portable tin storage box.
In light of these findings, CPSC urges consumers to cease using the Magnetic Ball Sets immediately, keep them out of reach of children, and properly dispose of them. The risk posed by these hazardous magnets is too high to ignore, and swift action is necessary to prevent further harm.
The Need for Enhanced Safety Measures
The CPSC remains committed to ensuring the safety of consumers and will continue to monitor the situation closely. Furthermore, manufacturers and sellers must prioritize compliance and adherence to safety regulations to protect consumers, particularly vulnerable populations like children.
Photo: PR Newswire


FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Instagram Outage Disrupts Thousands of U.S. Users
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 



